Globus Medical (GMED) Common Equity (2011 - 2026)

Globus Medical has reported Common Equity for 16 years, with the latest figure at $4.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 15.76% year-over-year to $4.7 billion; the trailing twelve-month figure through Mar 2026 stood at $4.7 billion (up 15.76% YoY), and the FY2025 full-year result was $4.6 billion, up 9.48% from the prior year.
• Common Equity for Q1 2026 stood at $4.7 billion, up from $4.6 billion in the prior quarter.
• The five-year high for Common Equity was $4.7 billion in Q1 2026, with the low at $1.7 billion in Q2 2022.
• Historically, Common Equity has averaged $3.4 billion across 5 years, with a median of $4.0 billion in 2023.
• Annual changes were most pronounced in 2023 — Common Equity surged 137.36% — and 2024, when it retreated 2.82%.
• Globus Medical's Common Equity stood at $1.8 billion in 2022, then jumped by 116.53% to $4.0 billion in 2023, then increased by 4.49% to $4.2 billion in 2024, then increased by 9.48% to $4.6 billion in 2025, then gained by 3.48% to $4.7 billion in 2026.
• The last three Common Equity figures came in at $4.7 billion (Q1 2026), $4.6 billion (Q4 2025), and $4.4 billion (Q3 2025), per Business Quant data.